Geoffrey Crouse was appointed Chief Executive Officer and a member of the Board of Directors of Syneron Candela, June 15, 2017. Geoff Crouse has successfully led businesses in the life sciences sector spanning capital equipment, diagnostics and tools. Prior to joining Syneron Candela, he served as Chief Executive Officer of Cord Blood Registry from 2012 to 2015, when the company was sold to AMAG Pharmaceuticals. Prior, he served as Chief Operating Officer of Immucor, a publicly traded company in the in-vitro diagnostics marketplace, and led Health Economics and Reimbursement Outcomes for Roche Diagnostics.
Geoff currently serves as a member of the Board of Directors at Invitae Corporation (NYSE: NVTA) and Prelude Fertility.
Geoff holds a BA in English from Boston College, an MBA and a Masters of Public Health, from the University of California, Berkeley.